Expression of the Functional Recombinant Interleukin-16 in E. coli and Mammalian Cell Lines

  • Kim, Seon-Young (Laboratory of Cell Biology, Korea Research Institute of Bioscience and Biotechnology) ;
  • Lee, Chang-Hun (Laboratory of Biochemical Genetics, National Heart, Lung, and Blood Institute, National Institute of Health) ;
  • Kim, Kyung-Joo (Laboratory of Cell Biology, Korea Research Institute of Bioscience and Biotechnology) ;
  • Kim, Yeon-Soo (Laboratory of Cell Biology, Korea Research Institute of Bioscience and Biotechnology)
  • Published : 2001.04.01


The C-terminal 393 bp region of the human interleukin-16 (IL-16) gene was cloned and expressed in E. coli along with mammalian cell lines. Recombinant IL-16 expressed from E. coli was 22 kDa on SDS-PAGE and showed 260% of chemoattractant activity at a concentration of $0.1\;{\mu}g/ml$. HeLa, COS, and Neuro-2a cells were transduced by recombinant retrovirus vector pLNC/IL-16/IRES/TK and the intracellular and secreted amounts of IL-16 produced by HeLa/IL-16/TK, COS/IL-16/TK, and Neuro-2a/IL-16/TK cells were determined by enzyme-linked immunosorbent assay (ELISA). HeLa/IL-16/TK $(1{\times}10^5)$ and COS/IL-16/TK $(1{\times}10^5)$ cells secreted 36.1 and 13.3 ng of IL-16 for 48 h, respectively. Forty-nine ng and 86.4 ng of IL-16 remained in the cell lysates of HeLa/IL-16/TK and COS/IL-16/TK. Intracellular and secreted amounts of IL-16 from Neuro-2a/IL-16/TK $(5{\times}10^5)$ cells during 24 h cultivation were 50 ng and 3.3 ng, respectively. Also, HeLa and COS cells wee stably transfected with mammalian expression vector pCRIII/IL-16. Both culture media and cell lysates prepared from HeLa/IL-16 cells and COS/IL-16 cells showed chemoattractant activity ranging from 190% to 460% as compared to the control experiment. Expression of the herpes simplex virus thymidine kinase (HSV0tk) gene in pLNC/IL-16/ IRES/TK bicistronic retroviral expression vector was verified by performing a genciclovir (GCV) sensitivity assay. Finally, IL-16 repressed Tat-transactivated human immunodeficiency virus type 1 long terminal repeat (HIV-1 LTR) promoter activity.


  1. J. Infect. Dis. v.179 Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression Amiel, C.;E. Darcissac;M. J. Truong;J. Dewulf;M. Loyens;Y. Mouton;A. Capron;G. M. Bahr
  2. Nature v.378 HIV suppression by interleukin-16 Baier, M.;A. Werner;N. Bannert;K. Metzner;R. Kurth
  3. J. Immunol. v.128 Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells Center, D. M.;W. Cruikshank
  4. J. Immunol. v.161 Tissue and T cell distribution of precursor and mature IL-16 Chupp, G. L.;E. A. Wright;D. Wu;M. Vallen-Mashikian;W. W. Cruikshank;D. M. Center;H. Kornfeld;J. S. Berman
  5. J. Immunol. v.128 Modulation of lymphocyte migration by human lymphokines. II. Puriffication of a lymphotactic factor (LCF) Cruikshank, W.;D. M. Center
  6. J. Immunol. v.138 Lymphokine activation of T4+ T lymphocytes and monocytes Cruikskank, W. W.;J. S. Berman;A. C. Theodore;J. Bernardo;D. M. Center
  7. J. Immunol. v.146 Lymphocyte chemoattractant factor induces CD4-dependent intracytoplasmic signaling in lymphocytes Cruikshank, W. W.;J. L. Greenstein;A. C. Theodore;D. M. Center
  8. Eur. J. Immunol. v.28 Interleukin-16, produced by synovial fibroblasts, mediates chemoattraction for CD4+ T lymphocytes in rheumatoid arthritis Franz, J. K.;S. A. Kolb;K. M. Hummel;F. Lahrtz;M. Neidhart;W. K. aicher;T. Pap;R. E. Gay;A. Fontana;S. Gay
  9. Cell Immunol. v.202 Immunosuppressive effect on T cell activation by interleukin-16-cDNA-transfected human squamous cell line [In Process Citation] Fujita, T.;Y. Matsumoto;I. Hirai;K. Ezoe;T. Saito;A. Yagihashi;T. Torigoe;K. Homma;S. Takahashi;W. W. Cruikshank;K. Jimbow;N. Sato
  10. Clin. Exp. Immunol. v.112 Recombinant human IL-16 inhibits HIV-1 replication and protects against activation-induced cell death (AICD) Idziorek, T.;J. Khalife;O. Billaut-Mulot;E. Hermann;M. Aumercier;Y. Mouton;A. Capron;G. M. Bahr
  11. Mol. Cells v.8 Production of high-titer retroviral vectors and detection of replication-competent retroviruses Kim, Y. S.;H. K. Lim;K. J. Kim
  12. J. Virol. v.67 The full-length Tat protein is required for TAR-independent, posttranscriptional trans activation of human immunodeficiency virus type 1 env gene expression Kim, Y. S.;A. T. Panganiban
  13. J. Virol. v.67 TAR-independent transactivation of the murine cytomegalovirus major immediate-early promoter by the Tat protein Kim, Y. S.;R. Risser
  14. J. Immunol. v.162 IL-16 as an anti-inflammatory cytokine in rheumatoid synovitis Klimiuk, P. A.;J. J. Goronzy;C. M. Weyand
  15. J. Microbiol. Biotechnol. v.9 Expression of human thrombopoietin in insect cells by polyhedrin-gp64 dual promoter baculovirus system Koh, Y.-W.;S. K. Park;K.-S. Kim;S.-R. Kim;J. K. Lee;J. M. Yang
  16. J. Microbiol. Biotechnol. v.10 Expression of enhanced green fluorescent protein from stably transformed Drosophila melanogaster S2 cells Lee, J.-M.;J.-H. Park;I. S. Chung
  17. J. Immunol. v.158 IL-16 represses HIV-1 promoter activity Maciaszek, J. W.;N. A. Parada;W. W. Cruikshank;D. M. Center;H. Kornfeld;G. A. Viglianti
  18. Virology v.167 Construction and use of a safe and efficient amphotropic packaging cell line Markowitz, D.;S. Goff;A. Bank
  19. J. Virol. v.65 Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus Miller, A. D.;J. V. Garcia;N. von Suhr;C. M. Lynch;C. Wilson;M. V. Eiden
  20. Hum. Gene Ther. v.11 A phase I study of intralesional administration of an adenovirus vector expressing the HSV-1 thymidine kinase gene (AdV.RSV-TK) in combination with escalating doses of ganciclovir in patients with cutaneous metastatic malignant melanoma Morris, J. C.;W. J. Ramsey;O. Wildner;H. A. Muslow;E. Aguilar-Cordova;R. M. Blaese
  21. J. Immunol. v.160 Synergistic activation of CD4+ T cells by IL-16 and IL-2 Parada, N. A.;D. M. Center;H. Kornfeld;W. L. Rodriguez;J. Cook;M. Vallen;W. W. Cruikshank
  22. J. Microbiol. Biotechnol. v.9 Purification and characterization of recombinant hepatitis C virus replicase Park, C. H.;Y. H. Kee;J. H. Lee;J. H. Oh;J. C. Park;H. J. Myung
  23. J. Microbiol. Biotechnol. v.10 Generation and characterization of cell-permeable green fluorescent protein mediated by the basic domain of human immunodeficiency virus type 1 Tat Park, J. S.;K.-A. Kim;J.-Y. Ryu;E.-Y. Choi;K.-S. Lee;S.-Y. Choi
  24. Nat. Med. v.3 Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells Ram, Z.;K. W. Culver;E. M. Oshiro;J. J. Viola;H. L. DeVroom;E. Otto;Z. Long;Y. Chiang;G. J. McGarrity;L. M. Muul;D. Katz;R. M. Blaese;E. H. Oldfield
  25. J. Exp. Med. v.173 CD4-mediated stimulation of human eosinophils: Lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration Rand, T. H.;W. W. Cruikshank;D. M. Center;P. F. Weller
  26. Hum. Gene Ther. v.11 Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses Sandmair, A. M.;S. Loimas;P. Puranen;A. Immonen;M. Kossila;M. Puranen;H. Hurskainen;K. Tyynela;M. Turunen;R. Vanninen;P. Lehtolainen;L. Paljarvi;R. Johansson;M. Vapalahti;S. Yla-Herttuala
  27. J. Immunol. v.164 Cultured human fibroblasts express constitutive IL-16 mRNA: cytokinc induction of active IL-16 protein synthesis through a caspase-3-dependent mechanism Sciaky, D.;W. Brazer;D. M. Center;W. W. Cruikashank;T. J. Smith
  28. J. Microbiol. Biotechnol. v.9 Expression and characterization of human T cell leukemia virus type-1 Env and Gag proteins Son, K. H.;B.-M. Kim;T.-Y. Lee;S.-R. Kim;K.-S. Kim;J. K. Lee;J. M. Yang
  29. Immunology v.99 Human B-cell lines constitutively express and secrete interleukin-16 Sharma, V.;J. L. Sparks;J. D. Vail
  30. J. Virol. v.73 Interleukin-16 inhibits human immunodeficiency virus type 1 entry and replication in marcorphages and in dendritic cells Truong, M. J.;E. C. Darcissac;E. Hermann;J. Dewulf;A. Capron;G. M. Bahr
  31. Nat. Med. v.3 IL-16 anti-HIV-1 therapy Viglianti, G. A.;N. A. Parada;J. W. Maciaszek;H. Kornfeld;D. M. Center;W. W. Cruikshank
  32. J. Biol. Chem. v.273 Processing and activation of pro-interleukin-16 by caspase-3 Zhang, Y.;D. M. Center;D. M. Wu;W. W. Cruikshank;J. Yuan;D. W. Andrews;H. Kornfeld
  33. J. Immunol. v.163 Processing, secretion, and anti- HIV-1 activity of IL-16 with or without a signal peptide in CD4+ T cells Zhou, P.;K. Devadas;D. Tewari;A. Jegorow;A. L. Notkins
  34. Nat. Med. v.3 Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression Zhou, P.;S. Goldstein;K. Devadas;D. Tewari;A. L. Notkins